These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10211 related articles for article (PubMed ID: 1317993)

  • 1. Tissue breakdown and exposure associated with orbital hydroxyapatite implants.
    Buettner H; Bartley GB
    Am J Ophthalmol; 1992 Jun; 113(6):669-73. PubMed ID: 1317993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical considerations in the placement of hydroxyapatite orbital implants.
    Sires BS; Dortzbach RK; Holds JB
    Ophthalmic Plast Reconstr Surg; 1997 Jun; 13(2):147-51. PubMed ID: 9185199
    [No Abstract]   [Full Text] [Related]  

  • 3. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants.
    Nunery WR; Heinz GW; Bonnin JM; Martin RT; Cepela MA
    Ophthalmic Plast Reconstr Surg; 1993 Jun; 9(2):96-104. PubMed ID: 8391837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of the Allen implant. 1967 to 1991.
    Fan JT; Robertson DM
    Ophthalmology; 1995 Mar; 102(3):510-6. PubMed ID: 7891992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of exposed hydroxyapatite orbital implants.
    Kim YD; Goldberg RA; Shorr N; Steinsapir KD
    Ophthalmology; 1994 Oct; 101(10):1709-15. PubMed ID: 7936570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enucleation with primary implant insertion for treatment of recalcitrant endophthalmitis and panophthalmitis.
    Abel AD; Meyer DR
    Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):220-6. PubMed ID: 15942499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos.
    Massry GG; Holds JB
    Ophthalmology; 1995 Jan; 102(1):161-6. PubMed ID: 7831032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enucleation with on-the-table evisceration. Is it a good technique?].
    Duong MH; Barraco P; Schapiro D; Ben Ayed H; Morax S
    J Fr Ophtalmol; 2001 Oct; 24(8):836-41. PubMed ID: 11894534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.
    Shields CL; Shields JA; Eagle RC; De Potter P
    Am J Ophthalmol; 1991 Mar; 111(3):363-6. PubMed ID: 1848039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant.
    De Potter P; Shields CL; Shields JA; Flanders AE; Rao VM
    Ophthalmology; 1992 May; 99(5):824-30. PubMed ID: 1375714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the hydroxyapatite ocular implant in the pediatric population.
    De Potter P; Shields CL; Shields JA; Singh AD
    Arch Ophthalmol; 1994 Feb; 112(2):208-12. PubMed ID: 8311774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.
    Shields CL; Shields JA; De Potter P; Singh AD
    Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants.
    el-Shahed FS; Sherif MM; Ali AT
    Ophthalmic Plast Reconstr Surg; 1995 Jun; 11(2):91-4. PubMed ID: 7654623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and management of complications associated with the hydroxyapatite implant.
    Kaltreider SA; Newman SA
    Ophthalmic Plast Reconstr Surg; 1996 Mar; 12(1):18-31. PubMed ID: 8652455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term follow up of bone derived hydroxyapatite orbital implants.
    Suter AJ; Molteno AC; Bevin TH; Fulton JD; Herbison P
    Br J Ophthalmol; 2002 Nov; 86(11):1287-92. PubMed ID: 12386091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of porous spherical orbital implants.
    Remulla HD; Rubin PA; Shore JW; Sutula FC; Townsend DJ; Woog JJ; Jahrling KV
    Ophthalmology; 1995 Apr; 102(4):586-93. PubMed ID: 7536909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series of shrinking hydroxyapatite orbital implants.
    Han LS; Keillor RB; Weatherhead RG
    Br J Ophthalmol; 2021 Oct; 105(10):1338-1340. PubMed ID: 34039563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyapatite orbital implants. Experience with 100 cases.
    McNab A
    Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
    Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyapatite motility implants in ocular prosthetics.
    Cowper TR
    J Prosthet Dent; 1995 Mar; 73(3):267-73. PubMed ID: 7760276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 511.